The aim was to compare the performance of in-vitro maturation (IVM) with in-vitro fertilisation (IVF) for patients with polycystic ovary syndrome (PCOS). Differences between IVM and IVF were investigated with regard to oocyte and embryo development, morphometric kinetics, live-birth rates, neonatal outcomes and the effects of the use of maternal serum for IVM culture. The findings of this thesis demonstrate that although IVM treatment is still inferior to IVF in some aspects, methodological advances have improved success rates markedly, particularly for frozen embryo treatment cycles. IVM is an effective option for treating PCOS infertility.
|Qualification||Doctor of Philosophy|
|Award date||18 Dec 2016|
|Publication status||Unpublished - 2016|